European Journal of Pediatrics

, Volume 169, Issue 12, pp 1511–1515

Clinical features of hospitalised children with 2009 H1N1 influenza virus infection

  • Carmelina Calitri
  • Clara Gabiano
  • Silvia Garazzino
  • Michele Pinon
  • Marisa Zoppo
  • Margherita Cuozzo
  • Carlo Scolfaro
  • Pier-Angelo Tovo
Original Paper

Abstract

Clinical features and outcome of 2009 H1N1 influenza virus in the paediatric setting is ill-defined. The epidemiologic and clinical features of children with confirmed H1N1 influenza virus infection admitted to an Italian tertiary paediatric hospital from August through December 2009 were evaluated. A total of 63 children (mean age 4.3 years) were studied; of these, 29 (46%) had chronic underlying diseases. The most frequent symptoms and signs at admission were fever (97%), cough (60%) and respiratory disturbances (24%). Forty patients (63.5%) had H1N1-related complications: 32 (51%) pulmonary diseases, three (5%) neurological disorders, such as acute encephalitis or acute disseminated encephalomyelitis, and two (3%) haematological alterations. Three patients were admitted to the Intensive Care Unit. Most children (81%) were treated with oseltamivir: one developed rash during treatment; no other adverse events were noticed. All children survived without sequelae. In conclusions, 2009 H1N1 influenza virus infection in children is associated with a wide spectrum of clinical manifestations. Neurological disorders are not exceptional complications. Oseltamivir therapy seems safe also in infants.

Keywords

H1N1 influenza virus Pneumonia Neurological complications 

References

  1. 1.
    Arguedas A, Soley C, Lindert K (2010) Responses to 2009 H1N1 vaccine in children 3 to 17 years of age. N Engl J Med 362:370–372CrossRefPubMedGoogle Scholar
  2. 2.
    CDC (2009) H1N1 flu. Interim guidance on specimen collection, processing, and testing for patients with suspected novel influenza A (H1N1) (swine flu) virus infection. Available at: http://www.cdc.gov/h1n1flu/specimencollection.htm. Accessed 13 May 2009
  3. 3.
    CDC (2009) H1N1 flu. Interim guidance for clinicians on identifying and caring for patients with swine-origin influenza A (H1N1) virus infection. Available at: http://www.cdc.gov/h1n1flu/identifying patients.htm. Accessed 16 Sept 2009
  4. 4.
    CDC (2009) H1N1 flu. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009–2010 season. Available at: http://www.cdc.gov/h1n1flu/recommendations.htm. Accessed 07 Dec 2009
  5. 5.
    CDC (2009) Surveillance for pediatric deaths associated with 2009 pandemic influenza a (H1N1) virus infection—United States, April–August 2009. MMWR 58:941–947Google Scholar
  6. 6.
    CDC (2009) Serum cross-reactive antibody response to a novel influenza a (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 58:521–524Google Scholar
  7. 7.
    CDC (2009) Neurologic complications associated with novel influenza A (H1N1) virus infection in children—Dallas, Texas, May 2009. MMWR 58:773–778Google Scholar
  8. 8.
    CDC (2009) CDC Estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April–October 17, 2009. Available at: http://www.cdc.gov/h1n1flu/estimates_2009_H1N1 influenza virus.htm. Accessed 12 Nov 2009
  9. 9.
    Chowell G, Bertozzi SM, Colchero MA et al (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361:674–679CrossRefPubMedGoogle Scholar
  10. 10.
    Fitzgerald DA (2009) Human swine influenza A (H1N1): practical advice for clinicians early in the pandemic. Paediatr Respir Rev 10:154–158CrossRefPubMedGoogle Scholar
  11. 11.
    Hackett S, Hill L, Patel J, Ratnaraja N et al (2009) Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet 374:605CrossRefPubMedGoogle Scholar
  12. 12.
    Ito Y, Ichiyama T, Kimura H et al (1999) Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol 58:420–425CrossRefPubMedGoogle Scholar
  13. 13.
    Jain R, Goldman RD (2009) Novel influenza A(H1N1): clinical presentation, diagnosis, and management. Pediatr Emerg Care 25:791–796CrossRefPubMedGoogle Scholar
  14. 14.
    Koliou M, Soteriades ES, Toumasi MM et al (2009) Epidemiological and clinical characteristics of influenza A(H1N1)v infection in children: the first 45 cases in Cyprus, June–August 2009. Euro Surveill 14 pii:19312Google Scholar
  15. 15.
    Larcombe PJ, Moloney SE, Schmidt PA (2009) Pandemic (H1N1) 2009: a clinical spectrum in the general paediatric population. Arch Dis Child. doi:10.1136/adc.2009.176859 Google Scholar
  16. 16.
    Libster R, Bugna J, Coviello S et al (2010) Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 362:45–55CrossRefPubMedGoogle Scholar
  17. 17.
    Morishima T, Togashi T, Yokota S et al (2002) Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 35:512–517CrossRefPubMedGoogle Scholar
  18. 18.
    National Center for Immunization and Respiratory Diseases, CDC (2009) Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58(RR-10):1–8Google Scholar
  19. 19.
    Nolan T, McVernon J, Skeljo M et al (2010) Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants and children: a randomized trial. JAMA 303:37–46CrossRefPubMedGoogle Scholar
  20. 20.
    Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S et al (2009) Emergence of a novel swine origin influenza A (H1N1) virus in humans. N Engl J Med 360:2605–2615CrossRefPubMedGoogle Scholar
  21. 21.
    O’Riordan S, Barton M, Yau Y et al (2010) Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 182:39–44PubMedGoogle Scholar
  22. 22.
    Shun-Shin M, Thompson M, Heneghan C et al (2009) Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials. BMJ 339:b3172. doi:10.1136/bmj.b3172 CrossRefPubMedGoogle Scholar
  23. 23.
    Toovey S (2008) Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis 6:114–124CrossRefPubMedGoogle Scholar
  24. 24.
    Tullu MS (2009) Oseltamivir. J Postgrad Med 55:225–230CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Carmelina Calitri
    • 1
  • Clara Gabiano
    • 1
  • Silvia Garazzino
    • 1
  • Michele Pinon
    • 1
  • Marisa Zoppo
    • 1
  • Margherita Cuozzo
    • 1
  • Carlo Scolfaro
    • 1
  • Pier-Angelo Tovo
    • 1
  1. 1.Department of PaediatricsUniversity of Turin, Regina Margherita Children’s HospitalTurinItaly

Personalised recommendations